Blood endocan as a biomarker for breast cancer recurrence
Our results support the clinical significance of endocan in breast cancer patients for detecting breast cancer recurrence.
Authors
- Kentaro Daiki
- Kanae Taruno (ORCID: https://orcid.org/0000-0002-7754-1548)
- Toshiko Yamochi
- Hirotaka Ota
- Aya Nagata (ORCID: https://orcid.org/0009-0008-4620-5681)
- Seigo Nakamura (ORCID: https://orcid.org/0000-0001-6597-9107)
- Fumiaki Sato (ORCID: https://orcid.org/0000-0001-8186-9290)
- Yoko Kanada
- Yoshinori Katō (ORCID: https://orcid.org/0000-0002-6218-8710)
- Katsuhide Igarashi
Institutions
- SHOWA Medical University (JP)
- Hoshi University (JP)
- SHOWA Medical University Fujigaoka Hospital (JP)
- Tokyo Rosai Hospital (JP)
Publication Details
- Journal
- Cancer Biomarkers
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3233/cbm-240034
- Citations
- 2
- Primary Topic
- Inflammation biomarkers and pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.48